CJC-1295 with DAC
Longevity SupportResearch ongoing — see primary literature for current evidence.
Sermorelin
Longevity SupportEndogenous GHRH analog; pituitary GH secretion restoration; age-related GH decline reversal
Clinical Decision Framework
When evaluating CJC-1295 with DAC versus Sermorelin for biological age reduction, the primary consideration is the specific hallmark of aging being targeted. While both compounds offer systemic healthspan benefits, their mechanisms of action are distinct.
When to prioritize CJC-1295 with DAC:
Select CJC-1295 with DAC when the primary clinical objective aligns with its core mechanism: long-acting ghrh analog with a drug affinity complex that binds albumin, extending half-life to 6-8 days for sustained gh elevation.. This is particularly relevant for protocols focused on sustained gh elevation with less frequent dosing..
When to prioritize Sermorelin:
Conversely, Sermorelin is the superior choice when targeting first 29 amino acids of endogenous ghrh that stimulates pituitary gh release through the ghrh receptor., making it the preferred agent for natural gh stimulation from the pituitary with a well-established safety record..
Begin Your Age Reversal Protocol for CJC-1295 with DAC or Sermorelin
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing